山(shan)東(dong)(dong)金(jin)城(cheng)醫(yi)(yi)藥(yao)集團股份有限(xian)公(gong)(gong)(gong)司(si)(簡稱“金(jin)城(cheng)醫(yi)(yi)藥(yao)”,股票代碼:300233)成(cheng)立(li)于(yu)2004年,創業(ye)板(ban)上(shang)市企業(ye)。目前,公(gong)(gong)(gong)司(si)擁有北京朗依(yi)制(zhi)藥(yao)有限(xian)公(gong)(gong)(gong)司(si)、上(shang)海(hai)(hai)金(jin)城(cheng)藥(yao)業(ye)有限(xian)公(gong)(gong)(gong)司(si)、廣東(dong)(dong)金(jin)城(cheng)金(jin)素(su)制(zhi)藥(yao)有限(xian)公(gong)(gong)(gong)司(si)、山(shan)東(dong)(dong)金(jin)城(cheng)生物(wu)藥(yao)業(ye)有限(xian)公(gong)(gong)(gong)司(si)、山(shan)東(dong)(dong)金(jin)城(cheng)醫(yi)(yi)藥(yao)化工(gong)有限(xian)公(gong)(gong)(gong)司(si)、山(shan)東(dong)(dong)金(jin)城(cheng)石墨烯科(ke)技有限(xian)公(gong)(gong)(gong)司(si)、意(yi)大利海(hai)(hai)寶(bao)露有限(xian)責任公(gong)(gong)(gong)司(si)等18家參控股公(gong)(gong)(gong)司(si)。公(gong)(gong)(gong)司(si)通過“實業(ye)+資本”雙輪(lun)驅動(dong)發展模式,已構建(jian)形成(cheng)獨具金(jin)城(cheng)特(te)色的(de)醫(yi)(yi)藥(yao)健康制(zhi)藥(yao)工(gong)業(ye)產業(ye)鏈(lian),業(ye)務范(fan)圍涉及生物(wu)制(zhi)藥(yao)、頭孢類醫(yi)(yi)藥(yao)中間(jian)體、特(te)色原料藥(yao)、終端制(zhi)劑、保健品、新材料等產業(ye)領域,并(bing)現已形成(cheng)年營業(ye)收(shou)入超20億(yi)元、總資產近50億(yi)的(de)產業(ye)規模。
山東金城醫(yi)(yi)藥(yao)集團(tuan)股(gu)份有限公司是以(yi)三、四代頭(tou)孢(bao)(bao)類醫(yi)(yi)藥(yao)中間(jian)體、特色(se)原(yuan)料藥(yao)、生物(wu)制藥(yao)、終端制劑(ji)以(yi)及婦兒產品(pin)等為主(zhu)業的科(ke)研、生產企業,其中,頭(tou)孢(bao)(bao)類醫(yi)(yi)藥(yao)中間(jian)體產品(pin)銷量、銷售(shou)收入連續(xu)多年位(wei)居行(xing)業前列,是重要的生物(wu)制藥(yao)生產基地以(yi)及國內醫(yi)(yi)藥(yao)健康產業集團(tuan)。主(zhu)導產品(pin)有谷胱(guang)甘肽(tai)(花青肽(tai)美品(pin)牌)、硝呋太爾膠囊(nang)(朗依品(pin)牌)、富馬酸(suan)比索洛爾膠囊(nang)(洛雅品(pin)牌)、牡(mu)蠣碳酸(suan)鈣咀(ju)嚼片(金娃寧(ning)品(pin)牌)、復方(fang)木香鋁鎂片(德(de)瑞夫品(pin)牌)等近(jin)百種。
當前,公司(si)堅(jian)持科學發展(zhan)(zhan),按照“大(da)健(jian)康(kang)、大(da)醫藥(yao)(yao),打(da)造具有金城(cheng)(cheng)特(te)色(se)制(zhi)藥(yao)(yao)產(chan)(chan)業(ye)(ye)(ye)(ye)鏈(lian)”的(de)產(chan)(chan)業(ye)(ye)(ye)(ye)定位和(he)“調(diao)整、轉型(xing)、升級(ji)、發展(zhan)(zhan)”的(de)戰(zhan)略思路,專注專注金城(cheng)(cheng)特(te)色(se)制(zhi)藥(yao)(yao)產(chan)(chan)業(ye)(ye)(ye)(ye)鏈(lian)三(san)大(da)方向(xiang)建(jian)(jian)設——“頭孢(bao)類(lei)抗生素終端制(zhi)劑產(chan)(chan)業(ye)(ye)(ye)(ye)鏈(lian),多肽類(lei)特(te)色(se)生物制(zhi)藥(yao)(yao)產(chan)(chan)業(ye)(ye)(ye)(ye)鏈(lian)和(he)婦科、調(diao)節(jie)免疫制(zhi)劑特(te)色(se)類(lei)產(chan)(chan)業(ye)(ye)(ye)(ye)鏈(lian) ”。同(tong)時,公司(si)加快“三(san)個平臺(tai)”建(jian)(jian)設(技術創新(xin)平臺(tai)、產(chan)(chan)業(ye)(ye)(ye)(ye)運營平臺(tai)、組(zu)織管控平臺(tai)),加快打(da)造“四支(zhi)隊(dui)(dui)伍(wu)(wu)(wu)”建(jian)(jian)設(企(qi)業(ye)(ye)(ye)(ye)家隊(dui)(dui)伍(wu)(wu)(wu)、中(zhong)高層管理隊(dui)(dui)伍(wu)(wu)(wu)、專業(ye)(ye)(ye)(ye)人才隊(dui)(dui)伍(wu)(wu)(wu)、熟練工人隊(dui)(dui)伍(wu)(wu)(wu)),積(ji)極實踐(jian)內涵式(shi)(shi)發展(zhan)(zhan)、外延式(shi)(shi)擴(kuo)張和(he)投資并購(gou)三(san)種發展(zhan)(zhan)方式(shi)(shi),著力將(jiang)公司(si)打(da)造成“科技化、生態化、規范化、品(pin)牌化、國際(ji)化”的(de)現代化醫藥(yao)(yao)健(jian)康(kang)產(chan)(chan)業(ye)(ye)(ye)(ye)集團,助推醫藥(yao)(yao)進步,創享健(jian)康(kang)生活,志(zhi)在(zai)成為醫藥(yao)(yao)健(jian)康(kang)產(chan)(chan)業(ye)(ye)(ye)(ye)創新(xin)型(xing)領軍企(qi)業(ye)(ye)(ye)(ye)。